University of Wisconsin School of Medicine and Public Health, Department of Medical Physics, Madison, Wisconsin 53705, USA.
Acta Oncol. 2010 Oct;49(7):991-6. doi: 10.3109/0284186X.2010.500302.
Important limitations for dose painting are due to treatment planning and delivery constraints. The purpose of this study was to develop a methodology for creating voxel-based dose painting plans that are deliverable using the clinical TomoTherapy Hi-Art II treatment planning system (TPS). Material and methods. Uptake data from a head and neck patient who underwent a [(61)Cu]Cu-ATSM (hypoxia surrogate) PET/CT scan was retrospectively extracted for planning. Non-uniform voxel-based prescriptions were converted to structured-based prescriptions for compatibility with the Hi-Art II TPS. Optimized plans were generated by varying parameters such as dose level, structure importance, prescription point normalization, DVH volume, min/max dose, and dose penalty. Delivery parameters such as pitch, jaw width and modulation factor were also varied. Isodose distributions, quality volume histograms and planning target volume percentage receiving planned dose within 5% of the prescription (Q(0.95-1.05)) were used to evaluate plan conformity. Results. In general, the conformity of treatment plans to dose prescriptions was found to be adequate for delivery of dose painting plans. The conformity was better as the dose levels increased from three to nine levels (Q(0.95-1.05): 69% to 93%), jaw decreased in width from 5.0cm to 1.05cm (Q(0.95-1.05): 81% to 93%), and modulation factor increased up to 2.0 (Q(0.95-1.05): 36% to 92%). The conformity was invariant to changes in pitch. Plan conformity decreased as the prescription DVH constraint (Q(0.95-1.05): 93% vs. 89%) or the normalization point (Q(0.95-1.05): 93% vs. 90%) deviated from the means. Conclusion. This investigation demonstrated the ability of the Hi-Art II TPS to create voxel-based dose painting plans. Results indicated that agreement in prescription dose and planned dose distributions for all plans were sensitive to physical delivery parameter changes in jaw width and modulation factors, but insensitive to changes in pitch. Tight constraints on target structures also resulted in decreased plan conformity while under a relaxed set of optimization parameters, plan conformity was increased.
剂量描绘的重要限制因素是由于治疗计划和交付的限制。本研究的目的是开发一种基于体素的剂量描绘计划的方法,该计划可以使用临床 TomoTherapy Hi-Art II 治疗计划系统 (TPS) 进行交付。材料和方法。回顾性提取了一位接受 [(61)Cu]Cu-ATSM(缺氧替代物)PET/CT 扫描的头颈部患者的摄取数据进行计划。非均匀体素基础处方被转换为基于结构的处方,以与 Hi-Art II TPS 兼容。通过改变剂量水平、结构重要性、处方点归一化、DVH 体积、最小/最大剂量和剂量惩罚等参数来生成优化的计划。还改变了输送参数,如螺距、颌宽和调制因子。等剂量分布、质量体积直方图和计划靶区体积接受处方剂量的 5%以内的百分比(Q(0.95-1.05))用于评估计划的一致性。结果。通常,发现治疗计划与剂量处方的一致性足以交付剂量描绘计划。当剂量水平从三级增加到九级时(Q(0.95-1.05):69%至 93%),颌宽从 5.0cm 减小到 1.05cm(Q(0.95-1.05):81%至 93%),调制因子增加到 2.0 时,一致性更好(Q(0.95-1.05):36%至 92%)。一致性与螺距的变化无关。当处方剂量直方图约束(Q(0.95-1.05):93%与 89%)或归一化点(Q(0.95-1.05):93%与 90%)偏离平均值时,一致性降低。结论。本研究证明了 Hi-Art II TPS 生成基于体素的剂量描绘计划的能力。结果表明,对于所有计划,处方剂量和计划剂量分布的一致性对颌宽和调制因子的物理输送参数变化敏感,但对螺距变化不敏感。在目标结构的严格约束下,计划一致性降低,而在一组较宽松的优化参数下,计划一致性增加。